Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaginal gene therapy.

Alicia Rodríguez-Gascón1, Ana Del Pozo-Rodríguez1, Arantxazu Isla1

  • 1Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de investigación Lascaray ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad, 7, 01006 Vitoria-Gasteiz, Spain.

Advanced Drug Delivery Reviews
|July 21, 2015
PubMed
Summary

Vaginal gene therapy shows promise for treating sexually transmitted infections and improving reproductive health. Preclinical studies highlight the vagina as an effective route for gene delivery, exploring various vectors and applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular epidemiology and pharmacokinetic-pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study.

Pharmaceutics·2026
Same author

Nanomedicines for DNA and interference RNA co-delivery: Combined gene therapy for Fabry disease.

International journal of pharmaceutics: X·2026
Same author

Patients' and community pharmacists' perceptions of a new service for medicines subject to additional monitoring.

The International journal of pharmacy practice·2026
Same author

Impact of Additional Monitoring on Pharmacovigilance and Pharmacists' Role: A Scoping Review.

Pharmacoepidemiology and drug safety·2025
Same author

Clinical efficacy, safety and pharmacokinetics of novel β-lactam/β-lactamase inhibitor combinations: a systematic review.

JAC-antimicrobial resistance·2025

Area of Science:

  • Reproductive Medicine
  • Gene Therapy
  • Infectious Diseases

Background:

  • Vaginal gene therapy is emerging as a key strategy for managing sexually transmitted infections.
  • DNA delivery via the vaginal tract is being explored to enhance reproductive outcomes in women with specific deficiencies.

Purpose of the Study:

  • To review the advantages and challenges of vaginal gene therapy.
  • To discuss current nucleic acid delivery systems (viral and non-viral vectors).
  • To present advances in using vaginal gene therapy for infectious diseases like HIV, HPV, and HSV.

Main Methods:

  • Literature review of preclinical investigations and existing research on vaginal gene therapy.
  • Analysis of viral and non-viral vector systems for vaginal DNA delivery.
Keywords:
Gene therapyNon-viral vectorsSexually transmitted infectionsVaginal deliveryViral vectors

Related Experiment Videos

  • Examination of therapeutic applications against specific infectious agents.

    • Main Results:

    • The vaginal tract demonstrates potential as an effective route for gene delivery, despite no products reaching clinical trials.
    • Various viral and non-viral vectors are being investigated for their efficacy and safety in vaginal gene therapy.
    • Significant progress has been made in applying vaginal gene therapy for conditions including HIV, HPV, and HSV.

    Conclusions:

    • Vaginal gene therapy offers a promising approach for the treatment and prevention of gynecological and sexually transmitted infections.
    • Further research and development are needed to translate preclinical findings into clinical applications.
    • The vaginal route presents unique opportunities and challenges for effective gene delivery in women's reproductive health.